α-Melanocyte-stimulating hormone regulates vascular NO availability and protects against endothelial dysfunction

Cardiovascular Research

Volumn 97, Issue 2, 2013, Pages 360-368

  Rinne, Petteri ^a   Nordlund, Wendy ^a   Heinonen, Ilkka ^a   Penttinen, Anna Maija ^a,d   Saraste, Antti ^a   Ruohonen, Suvi T ^a   Mäkelä, Satu ^a   Vähätalo, Laura ^a   Kaipio, Katja ^a   Cai, Minying ^b   Hruby, Victor J ^b   Ruohonen, Saku ^a   Savontaus, Eriika ^a,c  

^a UNIVERSITY OF TURKU   (Finland)

^b University of Arizona   (United States)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Endothelial function; Endothelial nitric oxide synthase; Melanocortin; Nitric oxide; Vasodilation

Indexed keywords

AFAMELANOTIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MELANOCORTIN 1 RECEPTOR; MELANOTAN II; NITRIC OXIDE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CARDIOVASCULAR AUTOREGULATION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EX VIVO STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ALPHA-MSH; ANIMALS; CELLS, CULTURED; CORONARY CIRCULATION; ENDOTHELIUM, VASCULAR; HUMANS; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; RECEPTOR, MELANOCORTIN, TYPE 1; SIGNAL TRANSDUCTION; VASODILATION;

EID: 84872558138     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs335     Document Type: Article

References (39)

1. Wikberg JE, Mutulis F. Targeting melanocortin receptors: an approach to treat weight disorders and sexual dysfunction. Nat Rev Drug Discov 2008;7:307-323.
2. Catania A, Gatti S, Colombo G, Lipton JM. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev 2004;56:1-29.
3. Mountjoy K, Robbins L, Mortrud M, Cone R. The cloning of a family of genes that encode the melanocortin receptors. Science 1992;257:1248-1251.
4. Lerner AB, McGuire JS. Effect of alpha-and betamelanocyte stimulating hormones on the skin colour of man. Nature 1961;189:176-179.
5. Hadley ME. The Melanotropic Peptides. Boca Raton, FL: CRC Press Inc., 1988.
6. Bhardwaj R, Becher E, Mahnke K, Hartmeyer M, Schwarz T, Scholzen T et al. Evidence for the differential expression of the functional alpha-melanocyte- stimulating hormone receptor MC-1 on human monocytes. J Immunol 1997;158:3378-3384.
7. Adachi S, Nakano T, Vliagoftis H, Metcalfe DD. Receptor-mediated modulation of murine mast cell function by alpha-melanocyte stimulating hormone. J Immunol 1999;163:3363-3368.
8. Leoni G, Voisin MB, Carlson K, Getting S, Nourshargh S, Perretti M. The melanocortin MC(1) receptor agonist BMS-470539 inhibits leucocyte trafficking in the inflamed vasculature. Br J Pharmacol 2010;160:171-180.
9. Hartmeyer M, Scholzen T, Becher E, Bhardwaj RS, Schwarz T, Luger TA. Human dermal microvascular endothelial cells express the melanocortin receptor type 1 and produce increased levels of IL-8 upon stimulation with alpha-melanocytestimulating hormone. J Immunol 1997;159:1930-1937.
10. Scholzen TE, Brzoska T, Kalden DH, Hartmeyer M, Fastrich M, Luger TA et al. Expression of functional melanocortin receptors and proopiomelanocortin peptides by human dermal microvascular endothelial cells. Ann NY Acad Sci 1999;885:239-253.
11. Lindskog A, Ebefors K, Johansson ME, Stefánsson B, Granqvist A, Arnadottir M et al. Melanocortin 1 receptor agonists reduce proteinuria. J Am Soc Nephrol 2010;21: 1290-1298.
12. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-526.
13. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-376.
14. Arnold WP, Mittal CK, Katsuki S, Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci USA 1977;74:3203-3207.
15. Radomski MW, Palmer RM, Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 1990;87:5193-5197.
16. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1774-1777.
17. Sawyer TK, Sanfilippo PJ, Hruby VJ, Engel MH, Heward CB, Burnett JB et al. 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity. Proc Natl Acad Sci USA 1980;77:5754-5758.
18. Minder EI. Afamelanotide, an agonistic analog of a-melanocyte-stimulating hormone, in dermal phototoxicity of erythropoietic protoporphyria. Expert Opin Investig Drugs 2010;19:1591-1602.
19. Al-Obeidi F, Castrucci AM, Hadley ME, Hruby VJ. Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics. J Med Chem 1989;32:2555-2561.
20. Savontaus E, Breen T, Kim A, Yang L, Chua SJ, Wardlaw S. Metabolic effects of transgenic melanocyte-stimulating hormone overexpression in lean and obese mice. Endocrinology 2004;145:3881-3891.
21. Peiper U, Schmidt E, Laven R, Griebel L. Length-tension relationships in resting and activated vascular smooth muscle fibres. Pflugers Arch 1973;340:113-122.
22. Delaey C, Boussery K, Van de Voorde J. Contractility studies on isolated bovine choroidal small arteries: determination of the active and passive wall tension-internal circumference relation. Exp Eye Res 2002;75:243-248.
23. Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K et al. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest 2000;106:1521-1530.
24. Saraste A, KytöV, Saraste M, Vuorinen T, Hartiala J, Saukko P. Coronary flow reserve and heart failure in experimental coxsackievirus myocarditis. A transthoracic Doppler echocardiography study. Am J Physiol Heart Circ Physiol 2006;291:H871-875.
25. Hartley C, Reddy A, Madala S, Michael L, Entman M, Taffet G. Effects of isoflurane on coronary blood flow velocity in young, old and ApoE(-/-) mice measured by Doppler ultrasound. Ultrasound Med Biol 2007;33:512-521.
26. Kallio J, Pesonen U, Kaipio K, Karvonen MK, Jaakkola U, Heinonen OJ et al. Altered intracellular processing and release of neuropeptide Y due to leucine 7 to proline 7 polymorphism in the signal peptide of preproneuropeptide Y in humans. FASEB J 2001;15:1242-1244.
27. Juni A, Cai M, Stankova M,Waxman AR, Arout C, Klein G et al. Sex-specific mediation of opioid-induced hyperalgesia by the melanocortin-1 receptor. Anesthesiology 2010; 112:181-188.
28. Ni X, Butler A, Cone R, Humphreys M. Central receptors mediating the cardiovascular actions of melanocyte stimulating hormones. J Hypertens 2006;24:2239-2246.
29. Versteeg D, Van Bergen P, Adan R, De Wildt D. Melanocortins and cardiovascular regulation. Eur J Pharmacol 1998;360:1-14.
30. Kadowitz PJ, Chapnick BM, Kastin AJ. Comparison of alpha-MSH and several vasoactive substances on vascular resistance in the feline mesenteric vascular bed. Pharmacol Biochem Behav 1976;5:219-221.
31. Llanos AJ, Seron-Ferre M, Ramachandran J, Creasy RK, Heymann MA, Rudolph AM. Cardiovascular responses to alpha-melanocyte stimulating hormone during the perinatal period in sheep. Pediatr Res 1983;17:903-908.
32. Shimokawa H, Yasutake H, Fujii K, Owada MK, Nakaike R, Fukumoto Y et al. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol 1996;28:703-711.
33. Parsons SJ, Hill A, Waldron GJ, Plane F, Garland CJ. The relative importance of nitric oxide and nitric oxide-independent mechanisms in acetylcholine-evoked dilatation of the rat mesenteric bed. Br J Pharmacol 1994;113:1275-1280.
34. Gödecke A, Ziegler M, Ding Z, Schrader J. Endothelial dysfunction of coronary resistance vessels in apoE-/-mice involves NO but not prostacyclin-dependent mechanisms. Cardiovasc Res 2002;53:253-262.
35. Gwóźdź P, Drelicharz L, Kozlovski VI, Chlopicki S. Prostacyclin, but not nitric oxide, is the major mediator of acetylcholine-induced vasodilatation in the isolated mouse heart. Pharmacol Rep 2007;59:545-552.
36. Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 2003;284:R1-R12.
37. Naseem KM. The role of nitric oxide in cardiovascular diseases. Mol Aspects Med 2005;26:33-65.
38. Förstermann U, Li H. Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling. Br J Pharmacol 2011; 164:213-223.
39. Gatti S, Lonati C, Acerbi F, Sordi A, Leonardi P, Carlin A et al. Protective action of NDP-MSH in experimental subarachnoid hemorrhage. Exp Neurol 2012;234: 230-238.